U.S. Markets closed

Advanced Cell sees embryonic stem cell lines approved for funding

Advanced Cell Technology issued a statement on the U.S. Appeals Court’s ruling, upholding a lower court’s dismissal of the case, “Sherley v. Sebelius,” 11-5241, U.S. Court of Appeals for the District of Columbia Circuit (Washington), on the permissibility of federal funding of embryonic stem cell research. “This court ruling should be of considerable benefit to ACT and our embryonic stem cell-based clinical programs,” commented Gary Rabin, chairman and CEO. “It effectively removes major speed bumps for the National Institutes of Health in terms of approving the several stem cell lines that we have submitted for their consideration for funding. With Friday’s decisive ruling, we expect that a number of our embryonic stem cell lines will be approved for funding in coming months.”